| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |